NASDAQ-GS · traded in Congress
BioCryst Pharmaceuticals, BCRX
$8.51 -0.01 (-0.12%) Sep 25, 2026 4:41 AM ET
Market value$2.2B
P/E ratio-
Analyst target$17.00
52-week range-
Avg volume3,765,797
Dividend yieldN/A
Chart
Congress trades in BCRX
Members of Congress disclosed 1 transaction in BCRX in the filings we have processed.
| Traded | Member | Type | Amount | Filed |
|---|---|---|---|---|
| 07/10/2026 | Gilbert Cisneros CA31 | Purchase | $1,001 - $15,000 | 9/4/2026 filing |
Disclosed under the STOCK Act. Amounts are the ranges the law requires, filings can lag a trade by up to 45 days, and a disclosure is not evidence of wrongdoing. All congressional trades ›
Other companies
Price and key figures from Nasdaq's public quote data, refreshed through the day; the chart is live from TradingView. Congressional trades parsed from official House filings. Market information, not investment advice.